![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/03/2908119/0/en/CorMedix-Inc-Announces-Outpatient-Availability-of-DefenCath.html
https://www.globenewswire.com/news-release/2024/06/18/2900359/0/en/CorMedix-Inc-Receives-FDA-Feedback-on-Potential-Label-Expansion.html
https://www.globenewswire.com/news-release/2024/06/06/2894657/0/en/CorMedix-Inc-Announces-CMS-Grants-Pass-Through-Status-to-Defencath.html
https://www.globenewswire.com/news-release/2024/05/28/2889039/0/en/CorMedix-Inc-Announces-Commercial-Agreement-With-Top-Tier-Dialysis-Provider.html
https://www.globenewswire.com/news-release/2024/05/10/2879607/0/en/CorMedix-Inc-to-Participate-in-Two-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/05/09/2878658/0/en/CorMedix-Inc-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/05/06/2875837/0/en/CorMedix-Inc-To-Report-First-Quarter-2024-Financial-Results-and-Provide-a-Corporate-Update-on-May-9-2024.html
https://www.globenewswire.com/news-release/2024/04/19/2866146/0/en/CorMedix-Inc-Announces-CMS-Grants-TDAPA-to-DefenCath.html
https://www.globenewswire.com/news-release/2024/04/15/2862768/0/en/CorMedix-Inc-Announces-U-S-Inpatient-Commercial-Availability-of-DefenCath-Taurolidine-and-Heparin.html
https://www.globenewswire.com/news-release/2024/04/11/2861488/0/en/CorMedix-Inc-Announces-Abstracts-at-Upcoming-Society-for-Healthcare-Epidemiology-of-America-Conference.html